Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.
Yen-Wei PaiI-Chieh ChenJun-Fu LinXiao-Hui ChenHsin-Hua ChenMing-Hong ChangJin-An HuangChing-Heng LinPublished in: Diabetes, obesity & metabolism (2024)
The use of SGLT-2 inhibitor was associated with a lower risk of incident dementia and all-cause mortality in older adults with T2D compared to DPP-4 inhibitor and GLP-1 RA.